Chiba, Japan

Hisashi Suzuki

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hisashi Suzuki: Innovator in Actinium Radioisotope Production

Introduction

Hisashi Suzuki is a notable inventor based in Chiba, Japan. He has made significant contributions to the field of radioisotope production, particularly in the development of methods for producing Ac-225 solutions. His work has implications for medical applications, showcasing the intersection of innovation and healthcare.

Latest Patents

Hisashi Suzuki holds a patent for a method for producing Ac-225 solution and a method for producing medicine using Ac-225 solution. This innovative method involves several steps, including irradiating a radium target with particles to generate actinium radioisotopes, dissolving the target, and separating the isotopes to obtain a solution used in medicinal applications. The patent highlights the complexity and precision required in the production of these solutions, which are crucial for developing targeted therapies.

Career Highlights

Throughout his career, Suzuki has worked with prominent organizations such as Nihon Medi-Physics Company, Limited and the National Institutes for Quantum Science and Technology. His experience in these institutions has allowed him to refine his expertise in radioisotope production and its applications in medicine.

Collaborations

Hisashi Suzuki has collaborated with esteemed colleagues, including Yoshio Honda and Taku Ito. These partnerships have contributed to advancements in the field and have fostered a collaborative environment for innovation.

Conclusion

Hisashi Suzuki's contributions to the field of actinium radioisotope production exemplify the importance of innovation in medicine. His patented methods and collaborative efforts continue to influence the development of targeted therapies, showcasing the vital role of inventors in advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…